CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR/STAT3 under Hypoxic Conditions

CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR/STAT3 under Hypoxic Conditions

Carbonic anhydrases (CAs) are acid–base regulatory proteins that modulate a variety of physiological functions. Recent findings have shown that CAIX is particularly upregulated in glioblastoma multiforme (GBM) and is associated with a poor patient outcome and survival rate. An analysis of the GSE429...

Full description

Bibliographic Details
Main Authors:	Bor-Ren Huang, Yu-Shu Liu, Sheng-Wei Lai, Hui-Jung Lin, Ching-Kai Shen, Liang-Yo Yang, Dah-Yuu Lu
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	International Journal of Molecular Sciences
Subjects:	CAIX (carbonic anhydrase IX) hypoxic condition GBM (glioblastoma multiforme) motility M2 polarization
Online Access:	https://www.mdpi.com/1422-0067/21/16/5838

Similar Items

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer
by: Chong Hui Clara Ong, et al.
Published: (2022-06-01)

Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model
by: Yufei Wang, et al.
Published: (2022-03-01)

PIMT Binding to C-Terminal Ala459 of CAIX Is Involved in Inside-Out Signaling Necessary for Its Catalytic Activity
by: Veronika Simko, et al.
Published: (2020-11-01)

CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target
by: Astrid Drenckhan, et al.
Published: (2018-01-01)

Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer
by: Ellen L. Jones, et al.
Published: (2008-01-01)

An overview of carbohydrate-based carbonic anhydrase inhibitors
by: Doretta Cuffaro, et al.
Published: (2020-01-01)

Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer
by: Lina PENG, et al.
Published: (2015-11-01)

Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs
by: Lianhua Zhu, et al.
Published: (2017-09-01)

Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
by: Yufei Wang, et al.
Published: (2024-03-01)

ROC-1, P21 and CAIX as markers of tumor aggressiveness in bladder carcinoma in Egyptian patients
by: Dalia Rifaat Al-Sharaky, et al.
Published: (2020-04-01)

An update on anticancer drug development and delivery targeting carbonic anhydrase IX
by: Justina Kazokaitė, et al.
Published: (2017-11-01)

Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8
by: Ana I. Hernandez-Caballero, et al.
Published: (2020-08-01)

Molecular Resonance Imaging of the CAIX Expression in Mouse Mammary Adenocarcinoma Cells
by: Claudia Quattrociocchi, et al.
Published: (2023-09-01)

Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors
by: Moataz Shaldam, et al.
Published: (2021-10-01)

Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase <i>CA2</i> Gene as Resistance Factor
by: Ricarda Hannen, et al.
Published: (2019-06-01)

Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
by: Chen Zhang, et al.
Published: (2022-03-01)

CAIX-Mediated Control of LIN28/<i>let-7</i> Axis Contributes to Metabolic Adaptation of Breast Cancer Cells to Hypoxia
by: Adriana Gibadulinova, et al.
Published: (2020-06-01)

Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers
by: Marwa E. Elsherbiny, et al.
Published: (2021-04-01)

Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
by: Claudiu T. Supuran
Published: (2017-09-01)

Corrigendum: Quantitative Modulation of PpIX Fluorescence and Improved Glioma Visualization
by: Michael Reinert, et al.
Published: (2020-04-01)

Dynamic surveillance of tamoxifen‐resistance in ER‐positive breast cancer by CAIX‐targeted ultrasound imaging
by: Ying Li, et al.
Published: (2020-04-01)

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
by: Wilson Eduardo Furlan Matos Alves, et al.
Published: (2019-12-01)

Type 1 Sodium Calcium Exchanger Forms a Complex with Carbonic Anhydrase IX and Via Reverse Mode Activity Contributes to pH Control in Hypoxic Tumors
by: Veronika Liskova, et al.
Published: (2019-08-01)

Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression
by: Min-Chieh Hsin, et al.
Published: (2021-03-01)

Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells
by: Sumit Mukherjee, et al.
Published: (2018-01-01)

Molecular Modeling, Synthesis, and preliminary pharmacological evaluation of New Sulfonamide Derivatives as Selective Carbonic Anhydrase XII and IX inhibitors (Research)
by: Samer Tareq Jasim, et al.
Published: (2024-04-01)

Carbonic Anhydrase-IX Guided Albumin Nanoparticles for Hypoxia-mediated Triple-Negative Breast Cancer Cell Killing and Imaging of Patient-derived Tumor
by: Katyayani Tatiparti, et al.
Published: (2020-05-01)

Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII
by: Gaia Giuntini, et al.
Published: (2020-10-01)

Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors
by: Özlen Güzel-Akdemir, et al.
Published: (2018-01-01)

Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment
by: Geetha Venkateswaran, et al.
Published: (2020-11-01)

Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
by: Emily ePadfield, et al.
Published: (2015-01-01)

Restriction spectrum imaging of bevacizumab-related necrosis in a patient with GBM
by: Nikdokht eFarid, et al.
Published: (2013-09-01)

Inhibition of Carbonic Anhydrase IX Suppresses Breast Cancer Cell Motility at the Single-Cell Level
by: Agne Janoniene, et al.
Published: (2021-10-01)

Structures of the Type IX Secretion/Gliding Motility Motor from across the Phylum Bacteroidetes
by: Rory Hennell James, et al.
Published: (2022-06-01)

Monocarboxylate Transporter 4 Regulates Glioblastoma Motility and Monocyte Binding Ability
by: Sheng-Wei Lai, et al.
Published: (2020-02-01)

Editorial: GBM stem cells and the brain tumor microenvironment
by: Yunqing Li, et al.
Published: (2023-02-01)

Prognostic impact of a lymphocyte activation-associated gene signature in GBM based on transcriptome analysis
by: Yujia Lan, et al.
Published: (2021-08-01)

Role of extent of resection on the survival of glioblastoma multiforme
by: Dipak Chaulagain, et al.
Published: (2023-06-01)

Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2021-08-01)

Carbonic Anhydrase IX and Survivin in Colorectal Adenocarcinoma Cells: Slovakian Population Study
by: Zuzana Kováčová, et al.
Published: (2021-09-01)